67.51; H, 6.12; N, 5.20. C60H64BMnN4O6P2 requires C, 67.67; H,
6.06; N, 5.26%. 4b: IR: mCO 2014, 1956 (s) (KBr); 2017, 1960 (s)
(CH2Cl2) cm−1. 1H NMR (CD2Cl2, 25 ◦C) d: 7.60–6.82 (m, 38 H,
Ph), 5.50 (s, 4 H, CH2N), 3.66 (m, 8 H, CH2 phos), 2.37 (s, 6 H,
C60H64BMnN4O6P2 requires C, 67.67; H, 6.06; N, 5.26%. 5d: IR:
1
mCO 2015, 1947 (s) (KBr); 2023 (m), 1959 (s) (CH2Cl2) cm−1. H
NMR (CD2Cl2, 25 ◦C) d: 7.45–6.84 (m, 38 H, Ph), 3.69 (br, 8 H,
1
CH2), 2.48 (s, 6 H, CH3 p-tol), 1.20 (t, 12 H, CH3 phos). 31P{ H}
CH3 p-tol), 1.28 (t, 12 H, CH3 phos). 31P{ H} NMR (CD2Cl2,
NMR (CD2Cl2, 25 ◦C) d: A2 spin system, 116.3. KM/S cm2 mol−1
=
1
25 ◦C) d: A2 spin system, 167.2. KM/S cm2 mol−1 = 54.5. Found:
C, 68.21; H, 6.22; N, 5.05. C62H68BMnN4O6P2 requires C, 68.14;
H, 6.27; N, 5.13%. 5a: IR: mCO 2025, 1955 (s) (KBr); 2026, 1960
(s) (CH2Cl2) cm−1. 1H NMR (CD2Cl2, 25 ◦C) d: 7.60–6.84 (m, 40
H, Ph), 5.67 (s, 4 H, CH2N), 3.48, 3.37 (m,◦8 H, CH2 phos), 1.25
52.8. Found: C, 60.11; H, 5.46; N, 4.62. C60H64BN4O6P2Re requires
C, 60.25; H, 5.39; N, 4.68%. 6c: IR: mCO 2025, 1953 (s) (KBr); 2027,
1963 (s) (CH2Cl2) cm−1. 1H NMR (CD2Cl2, 25 ◦C) d: 7.50–6.84 (m,
1
50 H, Ph), 3.40 (qnt, 4 H, CH2), 1.06 (t, 6 H, CH3). 31P{ H} NMR
(CD2Cl2, 25 ◦C) d: A2 spin system, 95.9. KM/S cm2 mol−1 = 51.8.
Found: C, 64.23; H, 5.00; N, 4.64. C66H60BN4O4P2Re requires C,
64.34; H, 4.91; N, 4.55%).
1
(t, 12 H, CH3). 31P{ H} NMR (CD2Cl2, 25 C) d: A2 spin system,
◦
1
116.0. 13C{ H} NMR (CD2Cl2, 25 C) d: 199.4 (t, JCP = 18 Hz,
CO), 165–122 (m, Ph), 72.5 (s, CH2N), 65.5 (t, CH2 phos), 15.7 (t,
CH3). KM/S cm2 mol−1 = 53.9. Found: C, 60.08; H, 5.27; N, 4.76.
C60H64BN4O6P2Re requires C, 60.25; H, 5.39; N, 4.68%. 5b: IR:
mCO 2022, 1956 (s) (KBr); 2025, 1958 (s) (CH2Cl2) cm−1. 1H NMR
(CD2Cl2, 25 ◦C) d: 7.55–6.82 (m, 38 H, Ph), 5.52 (s, 4 H, CH2N),
3.42, 3.30 (m, 8 H, CH2 phos), 2.35 (s, 6 H,◦CH3 p-tol), 1.17 (t, 12
[M(g2-1,4-R215N4)(CO)2{PPh(OEt)2}2]BPh4 4a1, 5a1, 5b1 [M =
Mn 4, Re 5; R = C6H5CH2 a1, 4-CH3C6H4CH2 b1]. These com-
plexes were prepared exactly like the related unlabelled compounds
4a, 4b, 5b using the R15N3 azide as a reagent; yield ≥65% (4a1: IR:
mCO 2004, 1949 (s) (KBr); 2017, 1960 (s) (CH2Cl2) cm−1. 1H NMR
(CD2Cl2, 25 ◦C) d: 7.70–6.85 (m, 40 H, Ph), 5.56 (s, 4 H, CH2N),
1
H, CH3 phos). 31P{ H} NMR (CD2Cl2, 25 C) d: A2 spin system,
1
3.65 (m, br, 8 H, CH2 phos), 1.28 (t, 12 H, CH3). 31P{ H} NMR
◦
1
116.1. 13C{ H} NMR (CD2Cl2, 25 C) d: 199.6 (t, JCP = 17.4 Hz,
CO), 163–122 (m, Ph), 72.4 (s, CH2N), 65.4 (t, CH2 phos), 21.3 (s,
CH3 p-tol), 15.8 (t, CH3 phos). KM/S cm2 mol−1 = 52.6. Found:
C, 60.68; H, 5.65; N, 4.49. C62H68BN4O6P2Re requires C, 60.83;
H, 5.60; N, 4.58%. 6a: IR: mCO 2018, 1953 (s) (KBr); 2025, 1960
◦
1
(CD2Cl2, 25 C) d: A2 spin system, 168.0. 13C{ H} NMR (CD2Cl2,
25 ◦C) d: 223.1 (t, JCP = 35.8 Hz, CO), 165–122 (m, Ph), 72.4 (s,
CH2N), 65.9 (t, CH2 phos), 16.2 (t, CH3). 5a1: IR: mCO 2023, 1954
(s) (KBr); 2026, 1959 (s) (CH2Cl2) cm−1. 1H NMR (CD2Cl2, 25 ◦C)
d: 7.56–6.84 (m, 40 H, Ph), 5.67 (s, 4 H, CH2N), 3.48, 3.38 (m, 8 H,
(s) (CH2Cl2) cm−1. H NMR (CD2Cl2, 25 ◦C) d: 7.60–6.84 (m,
1
◦
CH2 phos), 1.23 (t, 12 H, CH3). 31P{ H} NMR (CD2Cl2, 25 C) d:
1
50 H, Ph), 5.58 (s, 4 H, CH2N), 3.39 (m, ◦4 H, CH2 phos), 1.21
◦
A2 spin system, 116.0. 13C{ H} NMR (CD2Cl2, 25 C) d: 199.5 (t,
JCP = 18.0 Hz, CO), 165–122 (m, Ph), 72.6 (s, CH2N), 65.5 (s, br,
CH2 phos), 15.8 (br, CH3). 5b1: IR: mCO 2022, 1955 (s) (KBr); 2025,
1
1
(t, 6 H, CH3). 31P{ H} NMR (CD2Cl2, 25 C) d: A2 spin system,
97.0. 13C{ H} NMR (CD2Cl2, 25 ◦C) d: 200.0 (t, JCP = 15 Hz,
1
CO), 165–122 (m, Ph), 72.7 (s, CH2N), 66.3 (t, CH2 phos), 15.8
(t, CH3). KM/S cm2 mol−1 = 56.6. Found: C, 64.64; H, 5.03; N,
4.54. C68H64BN4O4P2Re requires C, 64.81; H, 5.12; N, 4.45%. 6b:
1959 (s) (CH2Cl2) cm−1. H NMR (CD2Cl2, 25 ◦C) d: 7.60–6.83
1
(m, 38 H, Ph), 5.53 (s, 4 H, CH2N), 3.42, 3.30 (m, 8 H, CH2 phos),
1
2.36 (s, 6 H, CH3 p-tol), 1.18 (t, 12 H, CH3 phos). 31P{ H} NMR
1
IR: mCO 2021, 1959 ◦(s) (KBr); 2025, 1958 (s) (CH2Cl2) cm−1. H
(CD2Cl2, 25 ◦C) d: A2 spin system, 116.0).
NMR (CD2Cl2, 25 C) d: 7.60–6.87 (m, 48 H, Ph), 5.52 (s, 4 H,
CH2N), 3.34 (m, 4 H, CH2 phos), 2.23 (s, 6 H, CH3 p-tol), 1.17 (t,
=
[Re{ArC(H) NH)(CO)3{PPh(OEt)2}2]BPh4 7 [Ar = C6H5 a,
◦
1
6 H, CH3 phos). 31P{ H} NMR (CD2Cl2, 25 C) d: A2 spin system,
4-CH3C6H4 b]. An equimolar amount of triflic acid (0.37 mmol,
◦
95.9. 13C{ H} NMR (CD2Cl2, 25 C) d: 199.9 (t, JCP = 10.0 Hz,
CO), 165–122 (m, Ph), 72.4 (s, CH2N), 66.3 (t, CH2 phos), 21.2 (s,
CH3 p-tol), 15.7 (t, CH3 phos). KM/S cm2 mol−1 = 49.5. Found: C,
65.35; H, 5.23; N, 4.28. C70H68BN4O4P2Re requires C, 65.26; H,
5.32; N, 4.35%).
33 lL) was added to a frozen solution of the hydride
1
ReH(CO)3{PPh(OEt)2}2 (0.37 mmol, 250 mg) in 10 cm3 of CH2Cl2
cooled to −196 ◦C. The solution was brought to room temperature,
stirred for about 1 h and then a slight excess of the appropriate
azide, C6H5CH2N3 or 4-CH3C6H4CH2N3 (0.44 mmol, 0.44 cm3 of
1 M solution in CH2Cl2) was added. The reaction mixture was
stirred at room temperature in the presence of sunlight for about
24 h and then the solvent was removed under reduced pressure. The
oil obtained was treated with ethanol (2 cm3) containing an excess
of NaBPh4 (0.74 mmol, 250 mg). The resulting solution was stirred
for 1 h and then allowed to stand at −25 ◦C. White microcrystals
slowly separated out from the solution, which were filtered off and
crystallised from ethanol; yield ≥35% (7a: IR (KBr): mNH 3328 (m);
[M(g2-1,4-R2N4)(CO)2P2]BPh4 4, 5, 6 [M = Mn 4, Re 5, 6; P =
PPh(OEt)2 4, 5, PPh2(OEt) 6; R = C6H5 c, 4-CH3C6H4 d]. These
complexes were prepared as for the related aliphatic species 4a,
4b, 5a, etc., using a reaction time of 2 h; yield ≥75% (4c: IR: mCO
1
2021, 1966 (s) (KBr); 2021, 1967 (s) (CH2Cl2) cm−1. H NMR
(CD2Cl2, 25 ◦C) d: 7.59–6.88 (m, 40 H, Ph), 3.79 (qnt, 8 H,
CH2), 1.26 (t, 12 H, CH3). 31P{ H} NMR (CD2Cl2, 25 ◦C) d:
1
A2 spin system, 167.7. 13C{ H} NMR (CD2Cl2, 25 ◦C) d: 223.0
mCO 2070 (m), 1972, 1955 (s) cm−1. H NMR (CD2Cl2, 25 C) d:
◦
1
1
3
3
(t, JCP = 35.5 Hz, CO), 165–122 (m, Ph), 63.3 (d, CH2), 16.3 (d,
CH3). KM/S cm2 mol−1 = 55.3. Found: C, 67.27; H, 5.74; N, 5.49.
C58H60BMnN4O6P2 requires C, 67.19; H, 5.83; N, 5.40%. 4d: IR:
8.99 (d, 1 H, JHH = 15 Hz, NH), 7.97 (d, 1 H, JHH = 15 Hz,
=
CH), 7.50–6.85 (m, 35 H, Ph), 3.87 (m, 8 H, CH2), 1.35 (t,
12 H, CH3). 31P{ H} NMR (CD2Cl2, 25 ◦C) d: A2 spin system,
1
mCO 2003, 1948 (s) (KBr); 2016 (m), 1963 (s) (CH2Cl2) cm−1. H
132.6. 13C{ H} NMR (CD2Cl2, 25 ◦C) d: 189.6, 189.5 (t, JCP
=
1
1
NMR (CD2Cl2, 25 ◦C) d: 7.50–6.91 (m, 38 H, Ph), 4.09, 3.79 (br,
8 H, CH2), 2.50 (s, 6 H, CH3 p-tol), 1.46, 1.26 (t, 12 H, CH3
10.5 Hz, CO), 180.7 (s, CH), 165–122 (m, Ph), 64.2 (t, CH2),
16.3 (t, CH3). KM/S cm2 mol−1 = 54.4. Found: C, 59.57; H, 5.22;
N, 1.33. C54H57BNO7P2Re requires C, 59.45; H, 5.27; N, 1.28%.
7b: IR (KBr): mNH 3338 (m); mCO 2068 (w), 1971, 1938 (s) cm−1. 1H
=
◦
1
phos). 31P{ H} NMR (CD2Cl2, 25 C) d: A2 spin system, 168.6.
◦
13C{ H} NMR (CD2Cl2, 25 C) d: 222.3 (t, JCP = 35.4 Hz, CO),
165–122 (m, Ph), 66.1 (m, CH2), 21.5 (s, CH3 p-tol), 16.2 (t, CH3
phos). KM/S cm2 mol−1 = 50.7. Found: C, 67.46; H, 6.10; N, 5.18.
1
NMR (CD2Cl2, 25 ◦C) d: 8.95 (d, 1 H, NH), 7.95 (d, 1 H, JHH
=
=
15 Hz, CH), 7.53–5.85 (m, 34 H, Ph), 3.90 (m, 8 H, CH2), 2.39 (s,
This journal is
The Royal Society of Chemistry 2007
Dalton Trans., 2007, 661–668 | 663
©